Prosecution Insights
Last updated: April 19, 2026

Allergan Pharmaceuticals International Limited

6 pending office actions

Portfolio Summary

6
Total Pending OAs
3
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18913492 METHODS OF TREATING MIGRAINE WEDDINGTON, KEVIN E 1629 Non-Final OA Oct 11, 2024
18359728 PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES HELLMAN, KRISTINA M 1654 Non-Final OA Jul 26, 2023
18215098 DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION MAEWALL, SNIGDHA 1612 Final Rejection Jun 27, 2023
17998763 COMPOSITIONS COMPRISING TROPOELASTIN CROSSLINKED TO HYALURONIC ACID AND THE METHODS OF USE THEREOF GAMETT, DANIEL C 1647 Final Rejection Nov 14, 2022
16558488 HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS MARTIN, PAUL C 1653 Non-Final OA Sep 03, 2019
16433298 TREATMENT OF MIGRAINE CHONG, YONG SOO 1623 Final Rejection Jun 06, 2019

Managing Allergan Pharmaceuticals International Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month